dc.contributor.author |
Maharaj, VJ
|
|
dc.date.accessioned |
2011-12-09T08:06:45Z |
|
dc.date.available |
2011-12-09T08:06:45Z |
|
dc.date.issued |
2011-12 |
|
dc.identifier.citation |
Maharaj, VJ. 2011. Summary reports for key Hoodia clinical studies. CSIR |
en_US |
dc.identifier.uri |
http://hdl.handle.net/10204/5375
|
|
dc.description |
2011 CSIR: Summary reports for key Hoodia clinical studies |
en_US |
dc.description.abstract |
The CSIR has acquired the reports to 14 clinical studies in which Hoodia has been assesses, using crude extracts and concentrated active ingredients formulated in a number of different ways. In many of the studies Hoodia was found to be generally safe and well tolerated, though in some subjects’ adverse events and tolerability issues were noted with the concentrated active ingredient extracts. During the periods 1999 to 2003 clinical studies performed by the licensee or its partners were not published however detailed clinical studies were produced on the studies. A synopsis of the findings of the key clinical performed during this period is made available through the CSIR web-based ResearchSpace |
en_US |
dc.language.iso |
en |
en_US |
dc.publisher |
CSIR |
en_US |
dc.subject |
Hoodia gordonii |
en_US |
dc.subject |
Hoodia clinical studies |
en_US |
dc.subject |
Clinical studies |
en_US |
dc.subject |
Human health |
en_US |
dc.subject |
Pharmacokinetics |
en_US |
dc.subject |
Phytopharm |
|
dc.subject |
Pharmaceutical development |
|
dc.subject |
Medical microbiology |
|
dc.subject |
Health sciences |
|
dc.subject |
Medical sciences |
|
dc.title |
Summary reports for key Hoodia clinical studies |
en_US |
dc.type |
Report |
en_US |
dc.identifier.apacitation |
Maharaj, V. (2011). <i>Summary reports for key Hoodia clinical studies</i> CSIR. Retrieved from http://hdl.handle.net/10204/5375 |
en_ZA |
dc.identifier.chicagocitation |
Maharaj, VJ <i>Summary reports for key Hoodia clinical studies.</i> CSIR, 2011. http://hdl.handle.net/10204/5375 |
en_ZA |
dc.identifier.vancouvercitation |
Maharaj V. Summary reports for key Hoodia clinical studies. 2011 [cited yyyy month dd]. Available from: http://hdl.handle.net/10204/5375 |
en_ZA |
dc.identifier.ris |
TY - Report
AU - Maharaj, VJ
AB - The CSIR has acquired the reports to 14 clinical studies in which Hoodia has been assesses, using crude extracts and concentrated active ingredients formulated in a number of different ways. In many of the studies Hoodia was found to be generally safe and well tolerated, though in some subjects’ adverse events and tolerability issues were noted with the concentrated active ingredient extracts. During the periods 1999 to 2003 clinical studies performed by the licensee or its partners were not published however detailed clinical studies were produced on the studies. A synopsis of the findings of the key clinical performed during this period is made available through the CSIR web-based ResearchSpace
DA - 2011-12
DB - ResearchSpace
DP - CSIR
KW - Hoodia gordonii
KW - Hoodia clinical studies
KW - Clinical studies
KW - Human health
KW - Pharmacokinetics
KW - Phytopharm
KW - Pharmaceutical development
KW - Medical microbiology
KW - Health sciences
KW - Medical sciences
LK - https://researchspace.csir.co.za
PY - 2011
T1 - Summary reports for key Hoodia clinical studies
TI - Summary reports for key Hoodia clinical studies
UR - http://hdl.handle.net/10204/5375
ER -
|
en_ZA |